82 related articles for article (PubMed ID: 20379752)
1. Evaluation of different generic in silico methods for predicting HLA class I binding peptide vaccine candidates using a reverse approach.
Gowthaman U; Chodisetti SB; Parihar P; Agrewala JN
Amino Acids; 2010 Nov; 39(5):1333-42. PubMed ID: 20379752
[TBL] [Abstract][Full Text] [Related]
2. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion.
Gowthaman U; Agrewala JN
J Proteome Res; 2008 Jan; 7(1):154-63. PubMed ID: 18034454
[TBL] [Abstract][Full Text] [Related]
3. Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
[TBL] [Abstract][Full Text] [Related]
4. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
5. Structural prediction of peptides binding to MHC class I molecules.
Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
[TBL] [Abstract][Full Text] [Related]
6. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
[TBL] [Abstract][Full Text] [Related]
7. EpiTOP--a proteochemometric tool for MHC class II binding prediction.
Dimitrov I; Garnev P; Flower DR; Doytchinova I
Bioinformatics; 2010 Aug; 26(16):2066-8. PubMed ID: 20576624
[TBL] [Abstract][Full Text] [Related]
8. Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.
Doytchinova IA; Flower DR
J Chem Inf Model; 2007; 47(1):234-8. PubMed ID: 17238269
[TBL] [Abstract][Full Text] [Related]
9. Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions.
Liu G; Carter B; Bricken T; Jain S; Viard M; Carrington M; Gifford DK
Cell Syst; 2020 Aug; 11(2):131-144.e6. PubMed ID: 32721383
[TBL] [Abstract][Full Text] [Related]
10. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties.
Cui J; Han LY; Lin HH; Zhang HL; Tang ZQ; Zheng CJ; Cao ZW; Chen YZ
Mol Immunol; 2007 Feb; 44(5):866-77. PubMed ID: 16806474
[TBL] [Abstract][Full Text] [Related]
11. EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.
Atanasova M; Patronov A; Dimitrov I; Flower DR; Doytchinova I
Protein Eng Des Sel; 2013 Oct; 26(10):631-4. PubMed ID: 23661105
[TBL] [Abstract][Full Text] [Related]
12. Peptide binding by class I and class II MHC molecules.
Batalia MA; Collins EJ
Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
[TBL] [Abstract][Full Text] [Related]
13. MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties.
Cui J; Han LY; Lin HH; Tang ZQ; Jiang L; Cao ZW; Chen YZ
Immunogenetics; 2006 Aug; 58(8):607-13. PubMed ID: 16832638
[TBL] [Abstract][Full Text] [Related]
14. Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
Bordner AJ; Abagyan R
Proteins; 2006 May; 63(3):512-26. PubMed ID: 16470819
[TBL] [Abstract][Full Text] [Related]
15. Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.
Salazar LG; Fikes J; Southwood S; Ishioka G; Knutson KL; Gooley TA; Schiffman K; Disis ML
Clin Cancer Res; 2003 Nov; 9(15):5559-65. PubMed ID: 14654536
[TBL] [Abstract][Full Text] [Related]
16. Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach.
Mehla K; Ramana J
Mol Biosyst; 2016 Mar; 12(3):890-901. PubMed ID: 26766131
[TBL] [Abstract][Full Text] [Related]
17. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
[TBL] [Abstract][Full Text] [Related]
18. Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.
Du QS; Wei YT; Pang ZW; Chou KC; Huang RB
Protein Eng Des Sel; 2007 Sep; 20(9):417-23. PubMed ID: 17681974
[TBL] [Abstract][Full Text] [Related]
19. Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.
Vider-Shalit T; Raffaeli S; Louzoun Y
Mol Immunol; 2007 Feb; 44(6):1253-61. PubMed ID: 16930710
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
